Lawrence F. Eichenfield – SCMSJournal.com

Jun

2017

Vol. 36. No. 3

Highlights of Skin Disease Education Foundation’s 41st Annual Hawaii Dermatology SeminarTM

MORE

Jun

2013

Vol. 32. No. 2

Stratum Corneum Skin Barrier Maintenance and Restoration: Evidence-Based Approach to Cleansing and Other Skin Care Practices

Lawrence F. Eichenfield, MD | Joseph F. Fowler, Jr, MD | Peter M. Elias, MD | Paul Horowitz, MD, FAAP | Renee P. McLeod, PhD, APRN-BC, CPNP, FAANP

MORE

Sep

2017

Vol. 36. No. 3

Curriculum United for Better Eczema Care: why, how, and what?

While various medical specialties treat eczema patients, care for these patients is largely fragmented and disorganized.

MORE

Dec

2017

Vol. 36. No. 4

Emerging Science and Management of Atopic Dermatitis, Introduction

Lawrence F. Eichenfield, MD

The landscape of atopic dermatitis has evolved rapidly in recent years. The introduction of crisaborole, a phosphodiesterase-4 inhibitor, enables clinicians to offer another nonsteroidal topical therapy to patients with mild to moderate disease. The approval of dupilumab—an interleukin-4 and interleukin-13 inhibitor and the first biologic to become available for the treatment of atopic dermatitis—has revolutionized the therapy of adults with moderate to severe disease.

MORE

Mar

2017

Vol. 36. No. 2

Meeting the Challenge of Atopic Dermatitis from Infancy to Adulthood, Introduction

Lawrence F. Eichenfield, MD

Dermatologists and primary care clinicians have been able to adequately manage most patients with atopic dermatitis (AD), using long-standing and familiar nonpharmacologic and pharmacologic interventions.

MORE